We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TTI market cap is 27.98M. The company's latest EPS is CAD -0.1010 and P/E is -7.13.
| Year End 31 December 2022 | 2020 | 2021 | 2021 | 2022 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31k | 0 | -1.39M | -3k | -3.61M |
| Net Income | -128k | -93k | -1.22M | -224k | -3.92M |
| Year End 31 December 2022 | 2020 | 2021 | 2021 | 2022 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 182k | 146k | 231k | 3.43M | 6.29M |
| Total Liabilities | 6k | 63k | 1.29M | 3.49M | 307k |
| Total Equity | 176k | 83k | -1.06M | -61k | 5.98M |
| Year End 31 December 2022 | 2020 | 2021 | 2021 | 2022 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -79k | -36k | -768k | -67k | -2.09M |
| Investing | N/A | N/A | N/A | N/A | 107k |
| Financing | 166k | N/A | 819k | 3.33M | 8.13M |
| Market Cap | 27.98M |
| Price to Earnings Ratio | -7.13 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.52 |
| Price to Book Ratio | 4.68 |
| Dividend Yield | - |
| Shares Outstanding | 38.86M |
| Average Volume (1 week) | 8.33k |
| Average Volume (1 Month) | 15.88k |
| 52 Week Change | -4.00% |
| 52 Week High | 1.06 |
| 52 Week Low | 0.60 |
| Spread (Intraday) | 0.04 (5.41%) |
| Company Name | Thiogenesis Therapeutics Corp |
| Address |
4 king street west, ste. 401 toronto, ontario M5H 1B6 |
| Website | https://www.thiogenesis.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
